Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
1.670
+0.120 (7.74%)
At close: Jul 22, 2025, 4:00 PM
1.710
+0.040 (2.40%)
After-hours: Jul 22, 2025, 7:25 PM EDT
Acumen Pharmaceuticals Employees
Acumen Pharmaceuticals had 61 employees as of December 31, 2024. The number of employees increased by 9 or 17.31% compared to the previous year.
Employees
61
Change (1Y)
9
Growth (1Y)
17.31%
Revenue / Employee
n/a
Profits / Employee
-$1,905,770
Market Cap
101.16M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 61 | 9 | 17.31% |
Dec 31, 2023 | 52 | 12 | 30.00% |
Dec 31, 2022 | 40 | 23 | 135.29% |
Dec 31, 2021 | 17 | 10 | 142.86% |
Dec 31, 2020 | 7 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
ABOS News
- 7 days ago - JCR Pharmaceuticals and Acumen Pharmaceuticals Announce Collaboration to Develop Therapy for Alzheimer's Disease, Enabled by J-Brain Cargo® Technology Platform - Business Wire
- 12 days ago - Acumen Pharmaceuticals to Present Studies on Cost Savings Associated with Use of pTau217 Screening Assay in Phase 2 ALTITUDE-AD Study and Sabirnetug Oligomer-Selectivity at the Alzheimer's Association International Conference (AAIC®) 2025 - GlobeNewsWire
- 2 months ago - Acumen Pharmaceuticals, Inc. (ABOS) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Acumen Pharmaceuticals to Participate in the Bank of America Healthcare Conference - GlobeNewsWire
- 2 months ago - Acumen Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025 - GlobeNewsWire
- 3 months ago - Acumen Pharmaceuticals Showcases pTau217 Trial Screening Progress in Phase 2 ALTITUDE-AD Trial and Preclinical Research Methods at AD/PD 2025 and AAN Annual Meeting - GlobeNewsWire
- 4 months ago - Acumen Pharmaceuticals, Inc. (ABOS) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2024 Financial Results on March 27, 2025 - GlobeNewsWire